- US-listed companies
- BIOLASE, INC
- Cash flow
BIOLASE, INC【BIOLQ】Cash flow
Market cap
$36.6
P/E ratio
| 2011/12 | 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | |
| Depreciation & amortization | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 3 |
| Stock-based compensation | 2 | 2 | 2 | 1 | - | 3 | 2 | 3 | 3 | 3 | 2 | 2 | 1 |
| Cash from operations | -13 | -2 | -9 | -16 | -18 | -11 | -18 | -14 | -13 | -13 | -17 | -27 | -14 |
| Capital expenditures | -0 | -1 | -1 | -0 | -2 | -1 | -1 | -1 | -0 | -0 | -1 | -4 | -1 |
| Cash from investing | -0 | -1 | -1 | -0 | -2 | -1 | -1 | -1 | -0 | -0 | -1 | -4 | -1 |
| Proceeds from issuance of term debt, net | - | - | - | - | - | - | - | 13 | 3 | - | - | - | - |
| Repayments of term debt | 3 | - | - | - | - | - | - | - | - | - | - | - | - |
| Cash from financing | 15 | 2 | 9 | 47 | -0 | 9 | 22 | 11 | 11 | 24 | 30 | 5 | 17 |
| Free cash flow | |||||||||||||
| FCF margin (%) | - | - | - |